The circulating tumor DNA (ctDNA) diagnostic accuracy for detecting phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations in breast cancer (BC) is under discussion. We aimed to compare plasma and tissue PIK3CA alterations, encompassing factors that could affect the results.
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis / Galvano, Antonio; Castellana, Luisa; Gristina, Valerio; La Mantia, Maria; Insalaco, Lavinia; Barraco, Nadia; Perez, Alessandro; Cutaia, Sofia; Calò, Valentina; Bazan Russo, Tancredi Didier; Francini, Edoardo; Incorvaia, Lorena; Mirisola, Mario Giuseppe; Vieni, Salvatore; Rolfo, Christian; Bazan, Viviana; Russo, Antonio. - In: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. - ISSN 1758-8340. - STAMPA. - 14:(2022), pp. 1-20. [10.1177/17588359221110162]
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis
Francini, EdoardoWriting – Review & Editing
;
2022
Abstract
The circulating tumor DNA (ctDNA) diagnostic accuracy for detecting phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations in breast cancer (BC) is under discussion. We aimed to compare plasma and tissue PIK3CA alterations, encompassing factors that could affect the results.
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIK3CA mutations by circulating tumor DNA in breast cancer.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
1.1 MB
Formato
Adobe PDF
|
1.1 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
